霍金斯公司
✦ 量化合理价值 计算方式说明
- 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为62.00-135.24。
- 当前价格比按平均倍数计算的合理价值(98.62)高33.5%。
估值 各估值倍数与自身5年区间的对比
同业对比 Specialty Chemicals
| 公司 | 市值 | 市盈率(TTM)i | 市净率i | 股息率i |
|---|---|---|---|---|
| 霍金斯公司 (HWKN) | 2.75B | 34.11 | 5.01 | 0.58% |
| Linde (LIN) | 229.77B | 32.16 | 5.88 | 1.24% |
| Sherwin-Williams (SHW) | 81.37B | 30.92 | 21.11 | 0.95% |
| Ecolab (ECL) | 80.98B | 38.78 | 8.05 | 0.98% |
| Air Products & Chemicals (APD) | 66.71B | -1,426.62 | 4.81 | 2.40% |
| PPG Industries (PPG) | 23.87B | 15.36 | 2.83 | 2.64% |
StockVane 追踪范围内同行业的其他公司。
Morningstar
当前股价低于晨星合理价值估算10.9%。
合理价值
Hawkins Inc earns a 4-star quantitative star rating, indicating our belief that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 9% discount to our quantitative fair value estimate of $145.96 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The firm's solid growth bolsters our valuation estimate. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. For example, the firm's EPS 5-year growth of 11.8% lies in the top 40% globally. The robust five-year track record of EPS growth is reason to be optimistic about the firm's shares. We believe this is a sign that shares could be cheap.
Conversely, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.1, for example, ranks in the top 45% globally. The market value of equity is low relative to the business' enterprise value, suggesting the company could be buried in debt if anything goes wrong. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.
经济护城河
The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
作者:Quantitative Equity Report
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
霍金斯公司 讨论区 0 条评论